Between 4 and 24 months , atropine-treated eyes demonstrated gradual myopic progression ( -0.40 D ) , accompanied by reduction in K ( -0.06 D ) and ACD ( -0.07 mm ) and increase in VCD ( 0.13 mm ) and AL ( 0.06 mm ) .